Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Walzl

Showing results (51-60 of 284) with videos related to

Pageof 29
Sort By:
Oncotarget|September 30, 2016
Successful TB treatment induces B-cells expressing FASL and IL5RA mRNAIlana C van Rensburg, Chandre Wagman, Kim Stanley, et al.
International Journal of Molecular Sciences|April 12, 2022
Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for <i>Mycobacterium tuberculosis</i> Infection and Insights from Tumor BiologyBrian S M Munansangu, Colin Kenyon, Gerhard Walzl, et al.
Plos Pathogens|April 19, 2019
Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunctionFrank Vrieling, Louis Wilson, Patrick C N Rensen, et al.
BMC Microbiology|January 18, 2014
Mycobacterium bovis BCG infection severely delays Trichuris muris expulsion and co-infection suppresses immune responsiveness to both pathogensHendrik J Nel, Nelita du Plessis, Leanie Kleynhans, et al.
Immunological Reviews|February 24, 2015
Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitusKatharina Ronacher, Simone A Joosten, Reinout van Crevel, et al.
Lancet (London, England)|May 22, 2010
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practiceRobert S Wallis, Madhukar Pai, Dick Menzies, et al.
The Lancet. Infectious Diseases|March 28, 2018
Tuberculosis: advances and challenges in development of new diagnostics and biomarkersGerhard Walzl, Ruth McNerney, Nelita du Plessis, et al.
Frontiers in Cellular and Infection Microbiology|December 12, 2022
Culture filtrate supplementation can be used to improve <i>Mycobacterium tuberculosis</i> culture positivity for spinal tuberculosis diagnosisCaroline G G Beltran, Rouxjeane Venter, Theresa N Mann, et al.
Frontiers in Ophthalmology|July 10, 2024
CXCL13, CXCL10 and CXCL8 as Indicators of Ocular and Neurological Involvement in Patients With Ocular Syphilis: An Observational Descriptive StudyLaurie W van der Merwe, Candice Snyders, Martin Kidd, et al.
Expert Review of Vaccines|April 8, 2014
The BCG replacement vaccine VPM1002: from drawing board to clinical trialStefan He Kaufmann, Mark F Cotton, Bernd Eisele, et al.
Pageof 29

Showing results (51-60 of 284) with videos related to

Sort By:
Pageof 29
Oncotarget|September 30, 2016
Successful TB treatment induces B-cells expressing FASL and IL5RA mRNAIlana C van Rensburg, Chandre Wagman, Kim Stanley, et al.
International Journal of Molecular Sciences|April 12, 2022
Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for <i>Mycobacterium tuberculosis</i> Infection and Insights from Tumor BiologyBrian S M Munansangu, Colin Kenyon, Gerhard Walzl, et al.
Plos Pathogens|April 19, 2019
Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunctionFrank Vrieling, Louis Wilson, Patrick C N Rensen, et al.
BMC Microbiology|January 18, 2014
Mycobacterium bovis BCG infection severely delays Trichuris muris expulsion and co-infection suppresses immune responsiveness to both pathogensHendrik J Nel, Nelita du Plessis, Leanie Kleynhans, et al.
Immunological Reviews|February 24, 2015
Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitusKatharina Ronacher, Simone A Joosten, Reinout van Crevel, et al.
Lancet (London, England)|May 22, 2010
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practiceRobert S Wallis, Madhukar Pai, Dick Menzies, et al.
The Lancet. Infectious Diseases|March 28, 2018
Tuberculosis: advances and challenges in development of new diagnostics and biomarkersGerhard Walzl, Ruth McNerney, Nelita du Plessis, et al.
Frontiers in Cellular and Infection Microbiology|December 12, 2022
Culture filtrate supplementation can be used to improve <i>Mycobacterium tuberculosis</i> culture positivity for spinal tuberculosis diagnosisCaroline G G Beltran, Rouxjeane Venter, Theresa N Mann, et al.
Frontiers in Ophthalmology|July 10, 2024
CXCL13, CXCL10 and CXCL8 as Indicators of Ocular and Neurological Involvement in Patients With Ocular Syphilis: An Observational Descriptive StudyLaurie W van der Merwe, Candice Snyders, Martin Kidd, et al.
Expert Review of Vaccines|April 8, 2014
The BCG replacement vaccine VPM1002: from drawing board to clinical trialStefan He Kaufmann, Mark F Cotton, Bernd Eisele, et al.
Pageof 29